Loading clinical trials...
Loading clinical trials...
Assessment of Bioequivalence Between Two Different Formulations of BI 201335 NA Soft Gelatine Capsules in Healthy Male Volunteers. (an Open-label, Randomised, Single-dose, Four-period Replicated Crossover Study)
Conditions
Interventions
BI 201335 NA 120 mg capsule
BI 201335 NA 120 mg capsule
+2 more
Locations
1
Japan
1220.53.08101 Boehringer Ingelheim Investigational Site
Sumida-ku,Tokyo, Japan
Start Date
October 1, 2012
Primary Completion Date
January 1, 2013
Completion Date
January 1, 2013
Last Updated
July 31, 2015
NCT06953479
NCT03135886
NCT05968573
NCT05042544
NCT05870969
NCT05361603
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions